000 | 00985 a2200301 4500 | ||
---|---|---|---|
005 | 20250512230434.0 | ||
264 | 0 | _c19840504 | |
008 | 198405s 0 0 eng d | ||
022 | _a0003-4967 | ||
024 | 7 |
_a10.1136/ard.43.2.351-c _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrennan, D M | |
245 | 0 | 0 |
_aSalicylate-NSAID interactions. _h[electronic resource] |
260 |
_bAnnals of the rheumatic diseases _cApr 1984 |
||
300 |
_a351-2 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aIbuprofen _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aSalicylates _xpharmacology |
650 | 0 | 4 | _aSalicylic Acid |
650 | 0 | 4 |
_aSerum Albumin _xmetabolism |
700 | 1 | _aAarons, L | |
773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 43 _gno. 2 _gp. 351-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.43.2.351-c _zAvailable from publisher's website |
999 |
_c6712095 _d6712095 |